1-4 of 4
Tara B. Gregory, MD
Close
Sort by
Journal Articles

A Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Final Analysis of Second Dose Expansion

Jesus G. Berdeja, MD, Tara B. Gregory, MD, Edward Faber, Jeffrey Matous, MD, Lowell Hart, MD, Joseph R. Mace, MD, Edward R. Arrowsmith, MD MPH, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4530.
https://doi.org/10.1182/blood.V128.22.4530.4530
Published: 2016
Journal Articles

A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts

Jesus G. Berdeja, MD, Tara B. Gregory, MD, Edward A. Faber, DO, Jeffrey V. Matous, MD, Lowell L. Hart, MD, Joseph R. Mace, MD, James D. Peyton, MD, James H. Essell, MD, Edward R. Arrowsmith, MD MPH, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1825.
https://doi.org/10.1182/blood.V126.23.1825.1825
Published: 2015
Journal Articles

Hematopoietic Cell Transplantation After Reduced Intensity Conditioning for Severe Paroxysmal Nocturnal Hemoglobinuria:

Rafic Farah, Georg Franke, MD, Tara B. Gregory, MD, Mark W. Brunvand, MD, Thoralf Lange, Rainer Storb, MD, Robert P. Witherspoon
Journal: Blood
Blood (2011) 118 (21): 2047.
https://doi.org/10.1182/blood.V118.21.2047.2047
Published: 2011
Journal Articles

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

George L. Chen, MD, Paul A. Carpenter, MD, Raewyn Broady, MBChB, FRACP, Tara B. Gregory, MD, Sally Arai, MD, Laura Johnston, MD, Mary E.D. Flowers, MD, Jan H. Beumer, PharmD, PhD, Jodie Mendolsohn, Xin Zhou, Spenser H. Perloff, Joanne M Otani, RN, MSN, David B Miklos, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1986.
https://doi.org/10.1182/blood.V118.21.1986.1986
Published: 2011